Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review

Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Hatice Kübra Öztürk, Ondřej Slanař, Danica Michaličková
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12088042/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review.
by: Hatice Kübra Öztürk, et al.
Published: (2025-01-01)

Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
by: Bassem I. Yamout, et al.
Published: (2018-01-01)

Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
by: Lineu Cesar Werneck, et al.

Multiple sclerosis and index of cardio-electrophysiological balance
by: Unal Ozturk, et al.
Published: (2025-05-01)

Special Edition: Therapeutic advances in multiple sclerosis
by: Patricia K. Coyle
Published: (2025-07-01)

MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis
by: Jihane Frikeche, et al.
Published: (2024-10-01)

The Relationship Between Autoimmune Disorders and Multiple Sclerosis: Clinical Insights and Therapeutic Approaches
by: Magdalena Iwan, et al.
Published: (2025-05-01)

Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Nasim Nehzat, et al.
Published: (2021-01-01)

Evaluation of the Efficacy, Safety, and Adherence to Oral Drug Therapy in Patients with Relapsing–Remitting Multiple Sclerosis
by: Paulius Sėdžius, et al.
Published: (2025-04-01)

Efficacy and safety of laquinimod versus placebo in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials
by: Malik Waleed Zeb Khan, et al.
Published: (2025-02-01)

Depression in Multiple Sclerosis: Lifestyle Interventions as an Additional Therapeutical Approach: A Narrative Review
by: Matea Hudolin, et al.
Published: (2025-03-01)

Multiple Sclerosis and Seizures: Clinical, Diagnostic and Therapeutic Correlations
by: C. Wood, et al.
Published: (2025-05-01)

The myths that drive therapeutic inertia in multiple sclerosis: a cost-effectiveness analysis of high-efficacy drugs in Brazil
by: Leonardo Zumerkorn Pipek, et al.
Published: (2024-01-01)

Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
by: Juan Ignacio Rojas, et al.
Published: (2016-03-01)

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients
by: Justyna Chojdak-Łukasiewicz, et al.
Published: (2025-06-01)

Adherence to Therapeutic Recommendations in Patients Suffering from Multiple Sclerosis
by: Joanna Olkiewicz, et al.
Published: (2020-06-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
by: İlke Coşkun Benlidayı, et al.
Published: (2015-08-01)

Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma
by: Xu Yang, et al.
Published: (2024-12-01)

In Silico Investigation of BTK as a Potent Immunomodulatory Target: Exploring Novel Therapeutic Approaches for Multiple Sclerosis
by: Afsheen Saba, et al.
Published: (2025-07-01)

Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis
by: Saeed Vaheb, et al.
Published: (2025-01-01)

The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches
by: Joo Han Lee, et al.
Published: (2017-01-01)

Editorial: Neuroanatomical and molecular biomarkers for multiple sclerosis progression and therapeutic response
by: Ignacio Casanova, et al.
Published: (2025-06-01)

Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective
by: Nagisa Nakata Arimitsu, et al.
Published: (2025-03-01)

Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study
by: André Aires Fernandes, et al.
Published: (2025-01-01)

Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
by: Federica Galota, et al.
Published: (2025-04-01)

USE OF INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH MULTIPLE SCLEROSIS: EFFICACY, SAFETY AND ADHERENCE TO THERAPY
by: O.V. Bykova, et al.
Published: (2009-10-01)

Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens
by: Stacy R. Smith, et al.
Published: (2025-03-01)

Cost of Illness of Multiple Sclerosis - A Systematic Review.
by: Olivia Ernstsson, et al.
Published: (2016-01-01)

Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
by: Daniela F Angelini, et al.
Published: (2013-01-01)

Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
by: Paola Saboya-Galindo, et al.
Published: (2024-01-01)

The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01)

The Clinical Efficacy and Safety of Nintedanib in the Treatment of Interstitial Lung Disease Among Patients With Systemic Sclerosis: Systematic Review
by: Khaled S. Al Oweidat, et al.
Published: (2025-01-01)

A specific vaccine to protect patients with multiple sclerosis from herpes zoster
by: Yara Dadalti Fragoso, et al.
Published: (2015-04-01)

Etiopathogenic and Therapeutic Considerations in a Multiple Sclerosis Case with Acute Toxic Hepatitis
by: Maria-Melania Dumitru-Martoiu, et al.
Published: (2025-03-01)

EVALUATION OF IMMUNOTOXICITY OF THE THERAPEUTIC DRUG PROLONGED ACTION FOR MULTIPLE SCLEROSIS ON RHESUS MONKEYS
by: A. B. Dzheliya, et al.
Published: (2015-10-01)

Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential
by: Mohammad Hosein Nemati, et al.
Published: (2025-04-01)

Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies
by: Lama Saleh Aljomah, et al.
Published: (2025-07-01)

Why this is not multiple sclerosis: a case based approach
by: Zaira Fernanda Martinho Nicolau, et al.
Published: (2015-01-01)

A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief review
by: María Fernanda Segovia, et al.
Published: (2025-03-01)

Yoga for multiple sclerosis: a systematic review and meta-analysis.
by: Holger Cramer, et al.
Published: (2014-01-01)